基本信息
浏览量:14
职业迁徙
个人简介
Research area
Daniel Razansky works at the interface of engineering, biology and medicine to devise novel tools for high performance functional and molecular imaging. The focus is on methods that can broadly impact pre-clinical research and clinical practice by delivering information presently not attainable with existing state-of-the-art imaging modalities. In particular, new imaging paradigms based on optoacoustics, ultrasonography, fluorescence microscopy, magnetic resonance imaging and their synergistic combinations are developed to enable multi-scale observations with unprecedented spatio-temporal resolution and deep penetration into living intact organisms. The group contributes to the creation of these new technologies in several diverse ways, from the establishment of solid theoretical background, inverse methods, and instrumentation to the development of in vivo small animal imaging methodologies and smart contrast enhancement approaches. Biomedical applications range from preclinical studies into neurodegeneration, functional neuroimaging, cancer and metabolic research to cardiovascular diagnostics and dermatologic applications in human subjects.
Daniel Razansky is Full Professor of Biomedical Imaging with double appointment at the Faculty of Medicine, University of Zurich and the Department of Information Technologies and Electrical Engineering of ETH Zurich, where he also serves as Director of the joint Preclinical Imaging Center. He earned PhD in Biomedical Engineering (2006) and MSc in Electrical Engineering (2001) from the Technion - Israel Institute of Technology and did postdoctoral research at the Center for Molecular Imaging Research of the Harvard Medical School in Boston. Prior to moving to Zurich in 2019, he was Professor of Molecular Imaging Engineering at the Technical University of Munich and Helmholtz Center Munich. His Lab pioneered a number of imaging technologies for pre-clinical research and clinical diagnostics successfully commercialized worldwide, among them the multi-spectral optoacoustic tomography (MSOT) and hybrid optoacoustic ultrasound (OPUS). Razansky’s research has been recognized by the German Innovation Prize and multiple awards from the ERC, NIH, SNF, DFG and HFSP. He is a Founding Editor of the Photoacoustics journal and serves on Editorial Boards of a number of journals published by Springer-Nature, Elsevier, IEEE and AAPM. He is also an elected Council Member of the European Society for Molecular Imaging (ESMI), serves on the IEEE Technical Committee on Biomedical Imaging and Image Processing and has chaired numerous international conferences of the OSA, WMIS, IEEE, ESMI and IFMBE. He is also an elected Fellow of the OSA and SPIE.
Daniel Razansky works at the interface of engineering, biology and medicine to devise novel tools for high performance functional and molecular imaging. The focus is on methods that can broadly impact pre-clinical research and clinical practice by delivering information presently not attainable with existing state-of-the-art imaging modalities. In particular, new imaging paradigms based on optoacoustics, ultrasonography, fluorescence microscopy, magnetic resonance imaging and their synergistic combinations are developed to enable multi-scale observations with unprecedented spatio-temporal resolution and deep penetration into living intact organisms. The group contributes to the creation of these new technologies in several diverse ways, from the establishment of solid theoretical background, inverse methods, and instrumentation to the development of in vivo small animal imaging methodologies and smart contrast enhancement approaches. Biomedical applications range from preclinical studies into neurodegeneration, functional neuroimaging, cancer and metabolic research to cardiovascular diagnostics and dermatologic applications in human subjects.
Daniel Razansky is Full Professor of Biomedical Imaging with double appointment at the Faculty of Medicine, University of Zurich and the Department of Information Technologies and Electrical Engineering of ETH Zurich, where he also serves as Director of the joint Preclinical Imaging Center. He earned PhD in Biomedical Engineering (2006) and MSc in Electrical Engineering (2001) from the Technion - Israel Institute of Technology and did postdoctoral research at the Center for Molecular Imaging Research of the Harvard Medical School in Boston. Prior to moving to Zurich in 2019, he was Professor of Molecular Imaging Engineering at the Technical University of Munich and Helmholtz Center Munich. His Lab pioneered a number of imaging technologies for pre-clinical research and clinical diagnostics successfully commercialized worldwide, among them the multi-spectral optoacoustic tomography (MSOT) and hybrid optoacoustic ultrasound (OPUS). Razansky’s research has been recognized by the German Innovation Prize and multiple awards from the ERC, NIH, SNF, DFG and HFSP. He is a Founding Editor of the Photoacoustics journal and serves on Editorial Boards of a number of journals published by Springer-Nature, Elsevier, IEEE and AAPM. He is also an elected Council Member of the European Society for Molecular Imaging (ESMI), serves on the IEEE Technical Committee on Biomedical Imaging and Image Processing and has chaired numerous international conferences of the OSA, WMIS, IEEE, ESMI and IFMBE. He is also an elected Fellow of the OSA and SPIE.
研究兴趣
论文共 561 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Cerebral cortex (New York, N.Y. : 1991)no. 1 (2024)
Optics lettersno. 6 (2024): 1469-1472
ADVANCED DRUG DELIVERY REVIEWS (2024): 115177-115177
Medical Imaging 2024: Ultrasonic Imaging and Tomography (2024)
Photons Plus Ultrasound: Imaging and Sensing 2024 (2024)
ADVANCED SCIENCEpp.e2308336-e2308336, (2024)
Anna Klimovskaia Susmelj,Berkan Lafci,Firat Ozdemir,Neda Davoudi,Xose Luis Dean-Ben,Fernando Perez-Cruz,Daniel Razansky
MEDICAL IMAGE ANALYSIS (2024): 103012-103012
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn